The "Valley of Death" in Innovative Drug Development

Advances in Tuberculosis Drug Development

A Novel Target for Mitochondrial Metabolism: Mechanism Analysis of Copper Death and Nanomedicine-Driven Paradigm Shift in Oncology Therapy

Direct Degradation Without E3: Protein Degradation Agent Without E3 Ligase Ligands Published in Nature Sub-journal

Antibody-oligonucleotide conjugates (AOC) emerge as a highly promising novel drug delivery system